Sign in
TXMD Stock Price, Chart, Stats & News
TherapeuticsMD, Inc.
Save
22.57M
Market cap
195.00x
Current P/E
2.33x
Forward P/E
TXMD chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 100.00% |
Operating margin | -97.10% |
Pretax margin | 0.36% |
Net margin | 10.80% |
Effective tax rate | -630.00% |
ROA | 0.78% |
ROE | 1.11% |
D/E | 0.24x |
Interest coverage ratio | -387.86x |
TXMD valuation
P/E | 195.00x |
P/S | 8.69x |
P/B | 0.89x |
P/CF | 11.75x |
P/FCF | 11.75x |
P/OCF | 11.75x |
PEG | 0.49x |
EV multiple | -25.60x |
About
TherapeuticsMD, Inc. is a U. S.-based pharmaceutical company dedicated to women's health. Its marketed portfolio includes IMVEXXY, prescribed for moderate to severe dyspareunia; BIJUVA, a bio-identical hormone replacement therapy combining 17ß-estradiol and progesterone, used to alleviate moderate to severe vasomotor symptoms; and ANNOVERA, an innovative vaginal ring designed for contraception.
Similar securities
Based on sector and market capitalization
Report issue